PD-Rx Pharmaceuticals, Inc. recalls ranitidine hydrochloride, USP ,150 mg tablets a) 14-count bottles ( NDC 43063-844-14); b) 30-count bottles (NDC
PD-Rx Pharmaceuticals recalls 150mg ranitidine hydrochloride tablets with potential nitrosodimethylamine (NDMA) levels above safety limits. Consumers should stop using affected bottles.
Stop using this now
CGMP Deviations: Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.
Contact the company & request your remedy
What happened, in plain English
PD-Rx Pharmaceuticals is recalling 150mg ranitidine hydrochloride tablets that may contain unsafe levels of nitrosodimethylamine (NDMA). This chemical has been linked to potential health risks, so affected consumers should stop using these products immediately. Read more at govinfonow.com/recall/37480-pd-rx-pharmaceuticals-recalls-ranitidine-tablets-due-to-nitrosodimethylamine-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/37480-pd-rx-pharmaceuticals-recalls-ranitidine-tablets-due-to-nitrosodimethylamine-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0826-2020
Cite this page
“PD-Rx Pharmaceuticals Recalls Ranitidine Tablets Due to Nitrosodimethylamine Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37480-pd-rx-pharmaceuticals-recalls-ranitidine-tablets-due-to-nitrosodimethylamine-risk. Based on FDA recall #D-0826-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0826-2020%22&limit=1).
Why it’s dangerous
The tablets may contain higher levels of nitrosodimethylamine (NDMA), a chemical that has been associated with potential health risks including liver damage. This risk occurs because the manufacturing process had deviations that led to unsafe levels of NDMA in the product.
Who’s affected
People who have the recalled ranitidine hydrochloride tablets (150mg) with specific lot numbers and expiration dates listed in the recall notice. Those who have taken these tablets recently are at higher risk.
How to tell if you have this one
Check for 150mg ranitidine hydrochloride tablets with the following lot numbers: H19E83, E19A82, H19B20, G19D77, C19D84, D19A77, D19E40, I19C45, E19E42, G19B41, H19C77, E19A34, H19B61, H19C82, C19A18, C19B13, D19B77, E19B76, I19B41, D19D51, F19C33. Also check the expiration dates listed in the recall notice.
- Brand
PD-Rx Pharmaceuticals- Category
Drug
What to do — step by step
Stop Using Tablets Now
Immediately stop using any recalled ranitidine hydrochloride tablets with the specific lot numbers and expiration dates listed in the recall notice.
Questions people ask
What is the risk of using these tablets?
The tablets may contain unsafe levels of nitrosodimethylamine (NDMA), which has been linked to potential health risks including liver damage.
Which lot numbers are affected?
The affected lot numbers include H19E83, E19A82, H19B20, G19D77, C19D84, D19A77, D19E40, I19C45, E19E42, G19B41, H19C77, E19A34, H19B61, H19C82, C19A18, C19B13, D19B77, E19B76, I19B41, D19D51, and F19C33.
How can I check if my tablets are affected?
Check the lot numbers and expiration dates on your tablets against the list provided in the recall notice.
Contact PD-Rx Pharmaceuticals
We’ve drafted a message you can send PD-Rx Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0826-2020 — PD-Rx Pharmaceuticals PD-Rx Pharmaceuticals Hello, I own a PD-Rx Pharmaceuticals that is covered by recall D-0826-2020 from PD-Rx Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0826-2020 (January 10, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0826-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.